Latest filing published 13 Jan 2020 for Infinity Pharmaceuticals, INC..
No signal scores available.
All filings by Seth A. Tasker on record concern Infinity Pharmaceuticals, Inc. We count 4 filings; the first trade dates from 31 October 2016 and the latest from 10 January 2020.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 13 January 2020, reports a share grant in Infinity Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations